Patch grafting, a novel strategy for transplantation of stem/progenitor organoids into porcine livers, has been found successful also for organoid transplantation into other normal or diseased solid organs in pigs and mice. Each organoid contained similar to 100 cells comprised of biliary tree stem cells (BTSCs), co-hepato/pancreatic stem/ progenitors, and partnered with early lineage stage mesenchymal cells (ELSMCs), angioblasts and precursors to endothelia and stellate cells. Patch grafting enabled transplantation into livers or pancreases of >= 10(8th) (pigs) or 10(6th-7th) (mice) organoids/patch. Graft conditions fostered expression of multiple matrix-metalloproteinases (MMPs), especially secretory isoforms, resulting in transient loss of the organ's matrix-dictated histological features, including organ capsules, and correlated with rapid integration within a week of organoids throughout the organs and without emboli or ectopic cell distribution. Secondarily, within another week, there was clearance of graft biomaterials, followed by muted expression of MMPs, restoration of matrix-dictated histology, and maturation of donor cells to functional adult fates.The ability of patch grafts of organoids to rescue hosts from genetic-based disease states was demonstrated with grafts of BTSC/ELSMC organoids on livers, able to rescue NRG/FAH-KO mice from type I tyrosinemia, a disease caused by absence of fumaryl acetoacetate hydrolase. With the same grafts, if on pancreas, they were able to rescue NRG/Akita mice from type I diabetes, caused by a mutation in the insulin 2 gene. The potential of patch grafting for cell therapies for solid organs now requires translational studies to enable its adaptation and uses for clinical programs.
Patch grafting of organoids of stem/progenitors into solid organs can correct genetic-based disease states / Zhang, Wencheng; Wauthier, Eliane; Lanzoni, Giacomo; Hani, Homayoun; Yi, Xianwen; Overi, Diletta; Shi, Lei; Simpson, Sean; Allen, Amanda; Suitt, Carolyn; Ezzell, Jennifer Ashley; Alvaro, Domenico; Cardinale, Vincenzo; Gaudio, Eugenio; Carpino, Guido; Prestwich, Glenn; Dominguez-Bendala, Juan; Gerber, David; Mathews, Kyle; Piedrahita, Jorge; Adin, Christopher; Sethupathy, Praveen; He, Zhiying; Reid, Lola M. - In: BIOMATERIALS. - ISSN 0142-9612. - 288:(2022), pp. 1-16. [10.1016/j.biomaterials.2022.121647]
Patch grafting of organoids of stem/progenitors into solid organs can correct genetic-based disease states
Overi, Diletta;Alvaro, Domenico;Cardinale, Vincenzo;Gaudio, Eugenio;Carpino, Guido;
2022
Abstract
Patch grafting, a novel strategy for transplantation of stem/progenitor organoids into porcine livers, has been found successful also for organoid transplantation into other normal or diseased solid organs in pigs and mice. Each organoid contained similar to 100 cells comprised of biliary tree stem cells (BTSCs), co-hepato/pancreatic stem/ progenitors, and partnered with early lineage stage mesenchymal cells (ELSMCs), angioblasts and precursors to endothelia and stellate cells. Patch grafting enabled transplantation into livers or pancreases of >= 10(8th) (pigs) or 10(6th-7th) (mice) organoids/patch. Graft conditions fostered expression of multiple matrix-metalloproteinases (MMPs), especially secretory isoforms, resulting in transient loss of the organ's matrix-dictated histological features, including organ capsules, and correlated with rapid integration within a week of organoids throughout the organs and without emboli or ectopic cell distribution. Secondarily, within another week, there was clearance of graft biomaterials, followed by muted expression of MMPs, restoration of matrix-dictated histology, and maturation of donor cells to functional adult fates.The ability of patch grafts of organoids to rescue hosts from genetic-based disease states was demonstrated with grafts of BTSC/ELSMC organoids on livers, able to rescue NRG/FAH-KO mice from type I tyrosinemia, a disease caused by absence of fumaryl acetoacetate hydrolase. With the same grafts, if on pancreas, they were able to rescue NRG/Akita mice from type I diabetes, caused by a mutation in the insulin 2 gene. The potential of patch grafting for cell therapies for solid organs now requires translational studies to enable its adaptation and uses for clinical programs.File | Dimensione | Formato | |
---|---|---|---|
Zhang_Patch_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.38 MB
Formato
Adobe PDF
|
1.38 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.